| Literature DB >> 19442301 |
Chad Kerksick1, Ashli Thomas, Bill Campbell, Lem Taylor, Colin Wilborn, Brandon Marcello, Mike Roberts, Emily Pfau, Megan Grimstvedt, Jasmine Opusunju, Teresa Magrans-Courtney, Christopher Rasmussen, Ron Wilson, Richard B Kreider.
Abstract
OBJECTIVE: To determine the safety and efficacy of altering the ratio of carbohydrate and protein in low-energy diets in conjunction with a popular exercise program in obese women.Entities:
Year: 2009 PMID: 19442301 PMCID: PMC2693519 DOI: 10.1186/1743-7075-6-23
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Figure 1Standard consort diagram illustrating people who provided interest in participating, those that were screened, how group assignments were made, who completed program and reasons for termination of participation.
Baseline anthropometric, dietary analysis, body composition and biochemical parameters for the high energy, high carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30) and no diet + no exercise control (CON).
| Grand Mean | HED | ND | VLCHP | LCMP | HCLP | CON | ||
| Age (years) | 38 ± 9 | 35 ± 10 | 37 ± 10 | 39 ± 7 | 38 ± 9 | 41 ± 8 | 32 ± 10 | 0.10 |
| Height (cm) | 164 ± 7 | 164 ± 6 | 163 ± 8 | 165 ± 6 | 165 ± 7 | 163 ± 7 | 163 ± 6 | 0.65 |
| Weight (kg) | 94 ± 19 | 93 ± 13 | 81 ± 13d | 108 ± 19 | 92 ± 18d | 87 ± 13d | 89 ± 18 | <0.001 |
| Body mass index | 35 ± 6 | 34 ± 4 | 31 ± 4d | 39 ± 7 | 34 ± 6d | 33 ± 4d | 34 ± 6 | <0.001 |
| (kg·m-2) | ||||||||
| Waist (cm) | 101 ± 13 | 104 ± 7 | 93 ± 12d | 108 ± 14 | 101 ± 13 | 96 ± 11d | 95 ± 13 | <0.001 |
| DXA fat-free mass (kg) | 49 ± 8 | 49 ± 7 | 43 ± 7d | 54 ± 7 | 48 ± 8d | 45 ± 6d | 48 ± 6 | <0.001 |
| DXA fat mass (kg) | 39 ± 11 | 37 ± 7 | 32 ± 7d | 46 ± 12 | 37 ± 10d | 35 ± 8d | 38 ± 9 | <0.001 |
| REE (kcals·d-1) | 1730 ± 300 | 1331 ± 193 | 1595 ± 228d, f | 1955 ± 278f | 1705 ± 249d, f | 1645 ± 222d, f | 1753 ± 274f | <0.001 |
| Systolic blood pressure (mm Hg) | 125 ± 13 | 127 ± 20 | 119 ± 10 | 129 ± 15 | 124 ± 9 | 126 ± 10 | 121 ± 14 | 0.10 |
| Diastolic blood pressure (mm Hg) | 83 ± 8 | 86 ± 14 | 79 ± 7 | 84 ± 8 | 83 ± 8 | 84 ± 7 | 79 ± 7 | 0.13 |
| VO2 (ml/kg/min) | 21 ± 5 | 22 ± 3 | 24 ± 5 | 19 ± 6 | 22 ± 5 | 22 ± 4 | 23 ± 5 | <0.001 |
| Grand Mean | HED | ND | VLCHP | LCMP | HCLP | CON | ||
| Total cholesterol | 5.0 ± 0.9 | 4.9 ± 0.8 | 5.1 ± 0.9 | 4.9 ± 0.7 | 5.0 ± 0.9 | 5.1 ± 1.1 | 5.3 ± 1.1 | 0.87 |
| (mmol·L-1) | ||||||||
| HDL cholesterol | 1.4 ± 0.3 | 1.3 ± 0.2 | 1.4 ± 0.3 | 1.3 ± 0.3 | 1.4 ± 0.3 | 1.4 ± 0.2 | 1.3 ± 0.3 | 0.36 |
| (mmol·L-1) | ||||||||
| LDL cholesterol | 3.0 ± 0.8 | 3.1 ± 0.7 | 3.1 ± 0.8 | 3.0 ± 0.6 | 2.8 ± 0.8 | 3.0 ± 1.0 | 3.3 ± 0.9 | 0.62 |
| (mmol·L-1) | ||||||||
| Triglycerides | 1.5 ± 0.9 | 1.0 ± 0.4 | 1.3 ± 0.5 | 1.6 ± 1.1 | 1.5 ± 0.9 | 1.5 ± 0.7 | 1.6 ± 0.8 | 0.50 |
| (mmol·L-1) | ||||||||
| Glucose | 5.3 ± 0.7 | 5.1 ± 0.5 | 5.0 ± 0.3 | 5.3 ± 0.7 | 5.3 ± 0.9 | 5.3 ± 0.5 | 5.2 ± 0.7 | 0.57 |
| (mmol·L-1) | ||||||||
| Insulin | 4.9 ± 4.0 | 3.3 ± 1.6 | 4.3 ± 2.3 | 6.0 ± 3.9 | 5.9 ± 6.0 | 3.8 ± 2.4 | 3.7 ± 2.0 | <0.05 |
| (pmol·L-1) | ||||||||
| HOMA-IR | 1.15 ± 1.0 | 0.75 ± 0.4 | 0.95 ± 0.5 | 1.43 ± 1.0 | 1.40 ± 1.4 | 0.89 ± 0.6 | 0.89 ± 0.6 | <0.05 |
| Leptin | 103 ± 48 | 98 ± 39 | 94 ± 35 | 107 ± 37 | 113 ± 67 | 99 ± 48 | 84 ± 39 | 0.56 |
| (pgm·L-1) | ||||||||
| Grand Mean | HED | ND | VLCHP | LCMP | HCLP | CON | ||
| Caloric intake (kcal/kg/day) | 22.4 ± 6.9 | 23.7 ± 4.2 | 21.2 ± 6.6 | 20.5 ± 7.5 | 23.3 ± 7.5 | 23.6 ± 6.0 | --- | 0.29 |
| Carbohydrate (g/kg/day) | 2.8 ± 1.1 | 3.0 ± 0.8 | 2.7 ± 0.8 | 2.4 ± 1.4 | 2.8 ± 1.1 | 3.1 ± 1.0 | --- | 0.19 |
| Protein (g/kg/day) | 0.88 ± 0.3 | 1.0 ± 0.2 | 0.8 ± 0.2 | 0.9 ± 0.4 | 0.9 ± 0.5 | 0.8 ± 0.2 | --- | 0.76 |
| Fat (g/kg/day) | 0.89 ± 0.3 | 0.9 ± 0.2 | 0.8 ± 0.4 | 0.9 ± 0.4 | 0.9 ± 0.4 | 0.9 ± 0.3 | --- | 0.90 |
All data is presented as means ± SD at baseline. Significance level was set at 0.05.
dDifferent than VLCHP, P < 0.001 – 0.05; fDifferent than HED, P < 0.001. NOTE: No other differences at baseline existed (P > 0.05).
Anthropometric, body mass, body composition and energy expenditure changes for the high energy, high carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30).
| Variable | Group | Mean | 14 Week Delta | Within Group | G × T |
| Waist (cm) | HED | -2.8 | (-4.3, -1.2)a | <0.001 | <0.05 |
| ND | -5.1 | (-8.8, -1.4)a | <0.05 | ||
| VLCHP | -6.3 | (-8.7, -3.8)a | <0.001 | ||
| LCMP | -6.7 | (-8.7, -4.8)a | <0.001 | ||
| HCLP | -5.7 | (-7.5, -3.9)a | <0.05 | ||
| CON | 8.2 | (+0.3, +16.1) | 0.16 | ||
| Body Mass (kg) | HED | -1.3 | (-3.2, +0.7)c | 0.26 | <0.001 |
| ND | -0.2 | (-1.0, +0.6) | 0.51 | ||
| VLCHP | -5.6 | (- 7.0, -4.3)a, b | <0.001 | ||
| LCMP | -6.5 | (-10.4, -2.6)a, b | <0.01 | ||
| HCLP | -4.0 | (-5.0, -3.0)a, b | <0.001 | ||
| CON | 1.4 | (-0.4, +3.2) | 0.28 | ||
| DXA Fat-Free Mass (kg) | HED | -0.1 | (-0.7, +0.4) | 0.36 | <0.05 |
| ND | 0.1 | (-0.6, +0.7) | 0.81 | ||
| VLCHP | -1.3 | (-1.8, -0.7) | <0.001 | ||
| LCMP | -1.1 | (-1.6, -0.6) | <0.001 | ||
| HCLP | -0.6 | (-1.1, -0.1) | <0.001 | ||
| CON | 0.5 | (-0.8, +1.8) | 0.62 | ||
| DXA Fat Mass (kg) | HED | -0.9 | (-2.7, +0.9)d | 0.38 | <0.001 |
| ND | -0.8 | (-1.6, +0.1) | 0.09 | ||
| VLCHP | -4.2 | (-5.2, -3.2)a, b | <0.001 | ||
| LCMP | -2.9 | (-4.0, -1.9)a, b | <0.001 | ||
| HCLP | -2.9 | (-3.8, -2.1)a, b | <0.001 | ||
| CON | 0.3 | (-1.8, +2.4) | 0.85 | ||
| DXA % Fat (%) | HED | -0.6 | (-1.8, +0.6) | 0.42 | 0.21 |
| ND | -0.6 | (-1.3+0.2) | 0.19 | ||
| VLCHP | -2.0 | (-2.7, -1.3) | <0.005 | ||
| LCMP | -1.7 | (-2.4, -0.9) | <0.001 | ||
| HCLP | -2.0 | (-2.6, -1.4) | <0.001 | ||
| CON | 0.0 | (-1.5, +1.5) | 0.96 | ||
| REE (kcals·d-1) | HED | 413 | (+264, +562) | <0.001 | 0.45 |
| ND | 83 | (-5, +135)e | 0.08 | ||
| VLCHP | -37 | (-84, +42)e | 0.06 | ||
| LCMP | 18 | (-58, +94)e | 0.52 | ||
| HCLP | 90 | (+22, +160)d, e | <0.05 | ||
| CON | -30 | (-105, +63)e | 0.91 | ||
Dietary intake is presented as energy (i.e. calories) intake: % carbohydrate: protein: fat. All data is presented as the mean plus the 95% confidence intervals for the delta response at week 14. Main effects for time are provided as within-group P-values. Group × time interaction effects are provided as GxT P-values. Significance level was set at 0.05.
aDifferent than CON, P < 0.05, bDifferent from ND, P < 0.05, cDifferent from LCMP, P < 0.05, dDifferent than VLCHP, P < 0.05, eDifferent from HED, P < 0.05.
Figure 2Delta change in waist circumference (cm) at 14 weeks. Data are presented as individual changes from baseline. Each respective individual group mean and 95% confidence interval are placed immediately to the right of each data group. HED = high-energy, high carbohydrate diet + exercise (n = 11); ND = no diet + exercise (n = 17); VLCHP = very low carbohydrate, high protein diet + exercise (n = 48); LCMP = Low carbohydrate, moderate protein + exercise (n = 37); HCLP = High carbohydrate, low protein + exercise (n = 41); CON = no diet + no exercise (n = 7). aDifferent than CON (p < 0.05).
Figure 3Delta change in body mass (kg) at 14 weeks. Data are presented as individual changes from baseline. Each respective individual group mean and 95% confidence interval are placed immediately to the right of each data group. HED = high-energy, high carbohydrate diet + exercise (n = 11); ND = no diet + exercise (n = 17); VLCHP = very low carbohydrate, high protein diet + exercise (n = 48); LCMP = Low carbohydrate, moderate protein + exercise (n = 37); HCLP = High carbohydrate, low protein + exercise (n = 41); CON = no diet + no exercise (n = 7). aDifferent than CON, P < 0.05. bDifferent than ND+E, P < 0.05. cDifferent than LCMP, P < 0.05.
Figure 4Delta change in DXA fat mass (kg) at 14 weeks. Data are presented as individual changes from baseline. Each respective individual group mean and 95% confidence interval are placed immediately to the right of each data group. HED = high-energy, high carbohydrate diet + exercise (n = 11); ND = no diet + exercise (n = 17); VLCHP = very low carbohydrate, high protein diet + exercise (n = 48); LCMP = Low carbohydrate, moderate protein + exercise (n = 37); HCLP = High carbohydrate, low protein + exercise (n = 41); CON = no diet + no exercise (n = 7). aDifferent than CON, P < 0.05. bDifferent than ND, P < 0.05. dDifferent than VLCHP, P < 0.05.
Figure 5Delta change in absolute resting energy expenditure (kcal·d. Each respective individual group mean and 95% confidence interval are placed immediately to the right of each data group. HED = high-energy, high carbohydrate diet + exercise (n = 11); ND = no diet + exercise (n = 17); VLCHP = very low carbohydrate, high protein diet + exercise (n = 48); LCMP = Low carbohydrate, moderate protein + exercise (n = 37); HCLP = High carbohydrate, low protein + exercise (n = 41); CON = no diet + no exercise (n = 7). dDifferent from VLCHP, P < 0.05. eDifferent from all other groups, P < 0.05.
Cardiorespiratory and muscular fitness changes for the high energy, high carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30).
| Variable | Group | Mean | 14 Week Delta | Within Group | G × T |
| Max VO2 (ml·kg·min--1) | HED | 1.0 | (-0.79, +2.73) | 0.48 | <0.05 |
| ND | 0.8 | (-1.45, +3.00) | 0.27 | ||
| VLCHP | 3.6 | (+2.30, +4.94) | <0.001 | ||
| LCMP | 1.1 | (+0.13, +2.26)d | <0.01 | ||
| HCLP | 0.9 | (+0.05, +1.67)d | <0.001 | ||
| CON | 0.1 | (-2.92, +3.13) | 0.52 | ||
| BP 1 RM (kg·kg-1) | HED | 0.06 | (+0.03, +0.09) | <0.01 | 0.44 |
| ND | 0.06 | (+0.04, +0.08) | <0.001 | ||
| VLCHP | 0.04 | (+0.03, +0.06) | <0.001 | ||
| LCMP | 0.09 | (+0.03, +0.16) | <0.05 | ||
| HCLP | 0.05 | (+0.03, +0.06) | <0.001 | ||
| CON | 0.02 | (-0.02, +0.05) | 0.59 | ||
| BP Lifting Volume (kg·kg-1) | HED | 1.8 | (-6.07, +9.70) | 0.20 | 0.35 |
| ND | 1.2 | (-3.99, +6.37) | 0.90 | ||
| VLCHP | 3.4 | (-0.29, +7.09) | 0.30 | ||
| LCMP | 1.0 | (-3.16, +5.25) | 0.18 | ||
| HCLP | 2.9 | (+0.31, +5.58) | <0.05 | ||
| CON | 2.7 | (-2.46, +7.81) | 0.59 | ||
| LP 1 RM (kg·kg-1) | HED | 0.2 | (-0.02, +0.47) | 0.11 | 0.38 |
| ND | 0.2 | (+0.09, +0.43) | <0.001 | ||
| VLCHP | 0.3 | (+0.22, +0.48) | <0.001 | ||
| LCMP | 0.5 | (+0.20, +0.73) | <0.005 | ||
| HCLP | 0.2 | (+0.13, +0.32) | <0.001 | ||
| CON | 0.1 | (-0.15, +0.37) | 0.54 | ||
| LP Lifting Volume (kg·kg-1) | HED | 2.0 | (-5.76, +9.84) | 0.45 | 0.32 |
| ND | 0.9 | (-4.32, +6.08) | 0.32 | ||
| VLCHP | 4.5 | (+0.93, +8.03) | <0.05 | ||
| LCMP | 3.9 | (-0.79, +8.58) | 0.24 | ||
| HCLP | 3.9 | (+1.40, +6.48) | <0.01 | ||
| CON | 2.3 | (-2.73, +7.38) | 0.28 | ||
Dietary intake is presented as energy (i.e., calories) intake: % carbohydrate: protein: fat. All data is presented as the mean plus the 95% confidence intervals for the delta response at week 14. Main effects for time are provided as within-group P-values. Group × time interaction effects are provided as GxT P-values.Significance level was set at 0.05.
dDifferent than VLCHP, P < 0.05
Lipid panel, glucose, insulin, HOMA and leptin changes for the high energy, high carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30).
| Variable | Group | Mean | 14 Week Delta | Within Group | G × T |
| Total Cholesterol (mmo·L-1) | HED | -0.14 | (-0.49, +0.22) | 0.46 | 0.90 |
| ND | -0.23 | (-0.63, +0.17) | 0.28 | ||
| VLCHP | -0.04 | (-0.19, +0.11) | 0.60 | ||
| LCMP | -0.13 | (-0.36, +0.11) | 0.31 | ||
| HCLP | -0.17 | (-0.33, -0.01) | <0.05 | ||
| CON | -0.15 | (-0.62, +0.32) | 0.55 | ||
| HDL Cholesterol (mmol·L-1) | HED | 0.05 | (-0.04, +0.14) | 0.28 | 0.78 |
| ND | -0.05 | (-0.16, +0.06) | 0.40 | ||
| VLCHP | 0.02 | (-0.03, +0.08) | 0.38 | ||
| LCMP | 0.01 | (-0.05, +0.07) | 0.75 | ||
| HCLP | -0.01 | (-0.07, +0.05) | 0.67 | ||
| CON | 0.02 | (-0.14, +0.18) | 0.80 | ||
| LDL Cholesterol (mmol·L-1) | HED | -0.28 | (-0.64, +0.07) | 0.15 | 0.54 |
| ND | -0.17 | (-0.50, +0.17) | 0.35 | ||
| VLCHP | -0.07 | (-0.23, +0.09) | 0.39 | ||
| LCMP | 0.05 | (-0.21, +0.31) | 0.71 | ||
| HCLP | -0.10 | (-0.27, +0.07) | 0.27 | ||
| CON | -0.23 | (-0.60, +0.14) | 0.27 | ||
| Triglycerides (mmol·L-1) | HED | 0.18 | (-0.09, +0.46)c | 0.22 | 0.31 |
| ND | -0.04 | (-0.31, +0.23) | 0.79 | ||
| VLCHP | -0.11 | (-0.32, +0.10) | 0.30 | ||
| LCMP | -0.33 | (-0.59, -0.06) | <0.05 | ||
| HCLP | -0.13 | (-0.30, +0.05) | 0.18 | ||
| CON | 0.12 | (-0.59, +0.33) | 0.63 | ||
| Insulin (pmol·L-1) | HED | 1.66 | (-0.91, +4.24) | 0.23 | 0.08 |
| ND | -0.45 | (-1.24, +0.33) | 0.28 | ||
| VLCHP | -1.23 | (-2.15, -0.30) | <0.05 | ||
| LCMP | -0.82 | (-2.45, +0.82) | 0.33 | ||
| HCLP | -0.10 | (-0.61, +0.41) | 0.69 | ||
| CON | 0.58 | (-1.95, +3.12) | 0.29 | ||
| Glucose (mmol·L-1) | HED | -0.12 | (-0.42, +0.18) | 0.45 | 0.68 |
| ND | -0.15 | (-0.32, +0.03) | 0.12 | ||
| VLCHP | -0.24 | (-0.43, -0.04) | <0.05 | ||
| LCMP | -0.08 | (-0.42, +0.26) | 0.65 | ||
| HCLP | -0.22 | (-0.35, -0.10) | <0.001 | ||
| CON | -0.08 | (-0.40, +0.25) | 0.66 | ||
| (HOMA-IR) | HED | 0.36 | (-0.26, +0.97) | 0.28 | 0.06 |
| ND | -0.12 | (-0.31, +0.07) | 0.23 | ||
| VLCHP | -0.35 | (-0.58, -0.12) | <0.01 | ||
| LCMP | -0.17 | (-0.57, +0.23) | 0.40 | ||
| HCLP | -0.06 | (-0.19, +0.07) | 0.38 | ||
| CON | 0.17 | (-0.18, +0.52) | 0.37 | ||
| Leptin (pg·mL-1) | HED | -11.4 | (-24.7, +2.0) | 0.41 | <0.01 |
| ND | -10.5 | (-20.2, -0.9) | <0.05 | ||
| VLCHP | -13.9 | (-24.0, -3.9) | 0.95 | ||
| LCMP | -28.5 | (-40.5, -16.5) | <0.001 | ||
| HCLP | -20.6 | (-29.3, -12.0) | <0.001 | ||
| CON | 24.9 | (+1.1, +48.7) | <0.001 | ||
Dietary intake is presented as energy (i.e. calories) intake: % carbohydrate: protein: fat. All data is presented as the mean plus the 95% confidence intervals for the delta response at week 14. Main effects for time are provided as within-group P-values. Group × time interaction effects are provided as GxT P-values. Significance level was set at 0.05.
cDifferent than LCMP, P < 0.05.